Concepedia

Liqiang Li

LL

6

Publications

159

Citations

6

H-Index

2010

Active since

Affiliations

Peking University(Current)

Peking University Cancer Hospital

National Medical Products Administration

Liqiang Li is an author at Peking University specializing in medicine, immunology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2010–2023

6

Publications

6

The cannabinoid receptor type 2 is time-dependently expressed during skeletal muscle wound healing in rats

Tian-Shui Yu, Zi-Hui Cheng, Liqiang Li et al. · International Journal of Legal Medicine · 2010 · 47 citations

, , +8

Preclinical evaluation and pilot clinical study of [68Ga]Ga-THP-APN09, a novel PD-L1 targeted nanobody radiotracer for rapid one-step radiolabeling and PET imaging

Xiaopan Ma, Xin Zhou, Biao Hu et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 31 citations

, , +13

IgG-Binding Nanobody Capable of Prolonging Nanobody-Based Radiotracer Plasma Half-Life and Enhancing the Efficacy of Tumor-Targeted Radionuclide Therapy

Biao Hu, Tianyu Liu, Liqiang Li et al. · Bioconjugate Chemistry · 2022 · 26 citations

[177Lu]Lu-labeled anti-claudin-18.2 antibody demonstrated radioimmunotherapy potential in gastric cancer mouse xenograft models

Ziqing Zeng, Liqiang Li, Jinping Tao et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 21 citations

, , +9

Comparison of posterior lumbar interbody fusion with transforaminal lumbar interbody fusion for treatment of recurrent lumbar disc herniation: A retrospective study

Liqiang Li, Yueju Liu, Peng Zhang et al. · Journal of International Medical Research · 2016 · 17 citations · Full text

Rows per page

1–5 of 6